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Dr Arun Seth obtained his PhD degree in 1981 in Molecular Biology from the University of New Brunswick, Canada. He performed post-doctoral research at National Cancer Institute, Maryland. His work on the mos oncogene contributed to the elucidation of the role of oncogenes in cancer. With Takis S Papas as Chief in the Laboratory of Molecular Oncology at the National Cancer Institute, Dr Seth and his group established the importance of the ETS gene family in areas as diverse as oncogenesis and bone development. He developed Ets2 transgenic mice which exhibit Down's syndrome-like skeletal abnormalities due to inducible over-expression of the Ets2 gene. Currently, he is associate professor in Department of Laboratory Medicine and Pathobiology at the University of Toronto and investigating the role of Ets1, Ets2 and target genes during osteoblast maturation and bone development. After receiving tenure at the NIH in 1992 he conducted a major breast cancer project in the NCI's Laboratory of Molecular Oncology. This work led to the isolation of more than 30 novel breast cancer associated genes. In order to investigate their roles in breast cancer progression, in 1995 he established and is also head of the Laboratory of Molecular Pathology at Sunnybrook & Women's College Health Sciences Center in Toronto, Canada, where he is developing high throughput diagnostic tools for molecular staging of breast tumors.
